Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Research Starter

Small-cell lung cancer.

ALSO KNOWN AS: Oat cell carcinoma; small-cell anaplastic carcinoma; undifferentiated small-cell carcinoma; intermediate cell type; and mixed small-cell/large-cell carcinoma....More
Salem Press Encyclopedia of Health, 2024. 3p.

Academic Journal

Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers.

Authors : Li, Xiaomi^1,2 (AUTHOR); Tong, Li¹ (AUTHOR); Wang, Shan³ (AUTHOR)

Source: BMC Medicine. 9/11/2024, Vol. 22 Issue 1, p1-15. 15p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

Authors : Yılmaz, Feride¹ (AUTHOR) ; Yaşar, Serkan¹ (AUTHOR); Tatar, Ömer Denizhan² (AUTHOR)

Source: BMC Cancer. 10/1/2024, Vol. 24 Issue 1, p1-11. 11p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The therapeutic effect of radiotherapy combined with systemic therapy compared to radiotherapy alone in patients with simple brain metastasis after first-line treatment of limited-stage small cell lung cancer: a retrospective study.

Authors : Gao, Xinyu^1,2 (AUTHOR); Liu, Tingting³ (AUTHOR); Fan, Min² (AUTHOR)

Source: World Journal of Surgical Oncology. 9/17/2024, Vol. 22 Issue 1, p1-8. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Serum tumor markers: potential indicators for occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients.

Authors : Jiang, Xu¹ (AUTHOR); Liu, Meng-Wen¹ (AUTHOR); Miao, Lei¹ (AUTHOR)

Source: Respiratory Research. 9/16/2024, Vol. 25 Issue 1, p1-5. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Combination of arsenic trioxide and apatinib synergistically inhibits small cell lung cancer by down-regulating VEGFR2/mTOR and Akt/c-Myc signaling pathway via GRB10.

Authors : Yu, Yao^1,2 (AUTHOR); Shang, Yu³ (AUTHOR); Shi, Si^1,2 (AUTHOR)

Source: Hereditas. 9/2/2024, Vol. 161 Issue 1, p1-16. 16p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer.

Authors : Chen, Tong¹ (AUTHOR); Wang, Mingzhao¹ (AUTHOR); Chen, Yanchao¹ (AUTHOR)

Source: Cell & Bioscience. 9/12/2024, Vol. 14 Issue 1, p1-32. 32p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

BUB1 induces AKT/mTOR pathway activity to promote EMT induction in human small cell lung cancer.

Authors : Wang, Moufeng^1,2,3; You, Lijie³; Su, Zhixiong³

Source: Scientific Reports. 9/4/2024, Vol. 14 Issue 1, p1-12. 12p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Immunotherapy Improves the Survival of Stage 4 Non–Small Cell Lung Cancer Patients at the US Population Level: The Real‐World Evidence.

Authors : Wei, Yuxuan¹ (AUTHOR); Zhang, Rui² (AUTHOR); Yin, Ruikang¹ (AUTHOR)

Source: Clinical Respiratory Journal. Sep2024, Vol. 18 Issue 9, p1-9. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer.

Authors : Barba, Andrés^1,2 (AUTHOR) ; López-Vilaró, Laura³ (AUTHOR) ; Ferre, Malena³ (AUTHOR)

Source: Pharmaceutics. Sep2024, Vol. 16 Issue 9, p1121. 14p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer.

Authors : Wen, Yang¹ (AUTHOR); Sun, Xue¹ (AUTHOR); Zeng, Lingge¹ (AUTHOR)

Source: Advanced Science. 10/16/2024, Vol. 11 Issue 38, p1-18. 18p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Small-cell lung cancer.

Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers.

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

The therapeutic effect of radiotherapy combined with systemic therapy compared to radiotherapy alone in patients with simple brain metastasis after first-line treatment of limited-stage small cell lung cancer: a retrospective study.

Serum tumor markers: potential indicators for occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients.

Combination of arsenic trioxide and apatinib synergistically inhibits small cell lung cancer by down-regulating VEGFR2/mTOR and Akt/c-Myc signaling pathway via GRB10.

Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer.

BUB1 induces AKT/mTOR pathway activity to promote EMT induction in human small cell lung cancer.

Immunotherapy Improves the Survival of Stage 4 Non–Small Cell Lung Cancer Patients at the US Population Level: The Real‐World Evidence.

ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer.

CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer.

اتصل بنا

اتبع